The Shocking Facts About Low-Fat Diets – Part 2

The Shocking Facts About Low-Fat Diets – Part 2


The Senate Select Committee on Nutrition and Human Needs, chaired by George McGovern during the years 1973 to 1977, actively promoted the use of vegetable oils. “Dietary Goals for the United States,” published by the committee, cited U.S. Department of Agriculture data on fat consumption, and stated categorically that “the over consumption of fat, generally, and saturated fat in particular. . . have been related to six of the ten leading causes of death. .” in the United States.

The report urged the American populace to reduce overall fat intake and to substitute polyunsaturates for saturated fat from animal sources – margarine and corn oil for butter, lard and tallow. Opposing testimony included a moving letter – buried in the voluminous report – by Dr. Fred Kummerow of the University of Illinois, urging a return to traditional whole foods and warning against the use of soft drinks. In the early 1970’s, Kummerow had shown that trans fatty acids caused increased rates of heart disease in pigs. A private endowment allowed him to continue his research – government funding agencies such as National Institutes of Health refused to give him further grants.

One unpublished study that was known to McGovern Committee members but not mentioned in its final report compared calves fed saturated fat from tallow and lard with those fed unsaturated fat from soybean oil. The calves fed tallow and lard did indeed show higher plasma cholesterol levels than the soybean oil-fed calves, and fat streaking was found in their aortas. Atherosclerosis was also enhanced. But the calves fed soybean oil showed a decline in calcium and magnesium levels in the blood, possibly due to inefficient absorption.

They utilized vitamins and minerals inefficiently, showed poor growth, poor bone development and had abnormal hearts. More cholesterol per unit of dry matter was found in the aorta, liver, muscle, fat and coronary arteries, a finding which led the investigators to the conclusion the lower blood cholesterol levels in the soybean-oil fed calves may have been the result of cholesterol being transferred from the blood to other tissues.

The calves in the soybean oil group also collapsed when they were forced to move around and they were unaware of their surroundings for short periods. They also had rickets and diarrhea. The McGovern Committee report continued dietary trends already in progress – the increased use of vegetables oils, especially in the form of partially hydrogenated margarines and shortenings.

In 1976, the FDA established GRAS (Generally Recognized as Safe) status for hydrogenated soybean oil. A report prepared by the Life Sciences Research Office of the Federation of American Scientists for Experimental Biology (LSRO-FASEB) concluded that “There is no evidence in the available information on hydrogenated soybean oil that demonstrates or suggests reasonable ground to suspect a hazard to the public when it is used as a direct or indirect food ingredient at levels that are now current or that might reasonably be expected in the future.”

When Mary Enig, a graduate student at the University of Maryland, read the McGovern committee report, she was puzzled. Enig was familiar with Kummerow’s research and she knew that the consumption of animal fats in America was not on the increase – quite the contrary, use of animal fats had been declining steadily since the turn of the century.

A report in the Journal of American Oil Chemists – which the McGovern Committee did not use – showed that animal fat consumption had declined from 104 grams per person per day in 1909 to 97 grams per day in 1972, while vegetable fat intake had increased from a mere 21 grams to almost 60. Total per capita fat consumption had increased over the period, but this increase was mostly due to an increase in unsaturated fats from vegetable oils – with 50 percent of the increase coming from liquid vegetable oils and about 41 percent from margarines made from vegetable oils.

She noted a number of studies that directly contradicted the McGovern Committee’s conclusions that “there is . . . a strong correlation between dietary fat intake and the incidence of breast cancer and colon cancer,” two of the most common cancers in America. Greece, for example, had less than one-fourth the rate of breast cancer compared to Israel but the same dietary fat intake. Spain had only one-third the breast cancer mortality of France and Italy but the total dietary fat intake was slightly greater.

Puerto Rico, with a high animal fat intake, had a very low rate of breast and colon cancer. The Netherlands and Finland both used approximately 100 grams of animal fat per capita per day but breast and colon cancer rates were almost twice in the Netherlands what they are in Finland. The Netherlands consumed 53 grams of vegetable fat per person compared to 13 in Finland.

A study from Cali, Columbia found a fourfold excess risk for colon cancer in the higher economic classes, which used less animal fat than the lower economic classes. A study on Seventh-Day Adventist physicians, who avoid meat, especially red meat, found they had a significantly higher rate of colon cancer than non-Seventh Day Adventist physicians. Enig analyzed the USDA data that the McGovern Committee had used and concluded that it showed a strong positive correlation with total fat and vegetable fat and an essentially strong negative correlation or no correlation with animal fat to total cancer deaths, breast and colon cancer mortality and breast and colon cancer incidence – in other words, use of vegetable oils seemed to predispose to cancer, and animal fats seemed to protect against cancer. She noted that the analysts for the committee had manipulated the data in inappropriate ways in order to obtain mendacious results.

Enig submitted her findings to the Journal of the Federation of American Societies for Experimental Biology (FASEB), in May, 1978, and her article was published in the FASEB’s Federation Proceedings in July of the same year – an unusually quick turnaround. The assistant editor, responsible for accepting the article, died of a heart attack shortly thereafter.

Enig’s paper noted that the correlations pointed a finger at the trans fatty acids and called for further investigation. Only two years earlier, the Life Sciences Research office, which is the arm of FASEB that does scientific investigations, had published the whitewash that had ushered partially hydrogenated soybean oil onto the GRAS list and removed any lingering constraints against the number one ingredient in factory-produced food.

Enig’s paper sent alarm bells through the industry. In early 1979, she received a visit from S. F. Reipma of the National Association of Margarine Manufacturers. Short, bald and pompous, Reipma was visibly annoyed. He explained that both his association and the Institute for Shortening and Edible Oils (ISEO) kept careful watch to prevent articles like Enig’s from appearing in the literature. Enig’s paper should never have been published, he said. He thought that ISEO was “watching out.”

“We left the barn door open,” he said, “and the horse got out.” Reipma also challenged Enig’s use of the USDA data, claiming that it was in error. He knew it was in error, he said, “because we give it to them.” A few weeks later, Reipma paid a second visit, this time in the company of Thomas Applewhite, an advisor to the ISEO and representative of Kraft Foods, Ronald Simpson with Central Soya and an unnamed representative from Lever Brothers. They carried with them – in fact, waved them in the air in indignation – a two-inch stack of newspaper articles, including one that appeared in the
National Enquirer, reporting on Enig’s Federation Proceedings article.

Applewhite’s face flushed red with anger when Enig repeated Reipma’s statement that “they had left the barn door open and a horse got out,” and his admission
that Department of Agriculture food data had been sabotaged by the margarine lobby.

The other thing Reipma told Enig during his unguarded visit was that he had called in on the FASEB offices in an attempt to coerce them into publishing letters to refute her paper, without allowing Enig to submit any counter refutation as was normally customary in scientific journals. He told Enig that he was “thrown out of the office” – an admission later confirmed by one of the FASEB editors. Nevertheless, a series of letters did follow the July 1978 article. On behalf of the ISEO, Applewhite and Walter Meyer of Procter and Gamble criticized Enig’s use of the data; Applewhite accused Enig of extrapolating from two data points, when in fact she had used seven.

In the same issue, John Bailar, Editor-in-Chief of the Journal of the National Cancer Institute, pointed out that the correlations between vegetable oil consumption and cancer were not the same as evidence of causation and warned against changing current dietary components in the hopes of preventing cancer in the future – which is of course exactly what the McGovern Committee did.

In reply, Enig and her colleagues noted that although the NCI had provided them with faulty cancer data, this had no bearing on the statistics relating to trans consumption, and did not affect the gist of their argument – that the correlation between vegetable fat consumption, especially trans fat consumption, was sufficient to warrant a more thorough investigation. The problem was that very little investigation was being done.

University of Maryland researchers recognized the need for more research in two areas. One concerned the effects of trans fats on cellular processes once they are built into the cell membrane. Studies with rats, including one conducted by Fred Mattson in 1960, indicated that the trans fatty acids were built into the cell membrane in proportion to their presence in the diet, and that the turnover of trans in the cells was similar to that of other fatty acids.

These studies, according to J. Edward Hunter of the ISEO, were proof that “trans fatty acids do not pose any hazard to man in a normal diet.” Enig and her associates were not so sure. Kummerow’s research indicated that the trans fats contributed to heart
disease, and Kritchevsky-whose early experiments with vegetarian rabbits were now seen to be totally irrelevant to the human model-had found that trans fatty acids raise cholesterol in humans. Enig’s own research, published in her 1984 doctoral dissertation, indicated that trans fats interfered with enzyme systems that neutralized carcinogens and increased enzymes that potentiated carcinogens.PROPORTION OF TRANS FAT USED?
The other area needing further investigation concerned just how much trans fat there was in a “normal diet” of the typical American. What had hampered any thorough research into the correlation of trans fatty acid consumption and disease was the fact that these altered fats were not considered as a separate category in any of the data bases then available to researchers. A 1970 FDA internal memo stated that a market basket survey was needed to determine trans levels in commonly used foods. The memo remained buried in the FDA files. The massive Health and Human Services NHANES II (National Health and Nutrition Examination Survey) survey, conducted during the years 1976 to 1980, noted the increasing US consumption of margarine, french fried potatoes, cookies and snack chips – all made with vegetable shortenings – without listing the proportion of trans.

Enig first looked at the NHANES II data base in 1987 and when she did, she had a sinking feeling. Not only were trans fats conspicuously absent from the fatty
acid analyses, data on other lipids made no sense at all. Even foods containing no trans fats were listed with faulty fatty acid profiles. For example, safflower oil was listed as containing 14% linoleic acid (a double bond fatty acid of the omega-6 family) when in fact it contained 80%; a sample of butter crackers was listed as containing 34% saturated fat when in fact it contained 78%. In general, the NHANES II data base tended to minimize the amount of saturated fats in common foods.

Over the years, Joseph Sampagna and Mark Keeney, both highly qualified lipid biochemists at the University of Maryland, applied to the National Science Foundation, the National Institutes of Health, the US Department of Agriculture, the National Dairy Council and the National Livestock and Meat Board for funds to look into the trans content of common American foods. Only the National Livestock and Meat Board came through with a small grant for equipment; the others turned them down. The pink slip from National Institutes of Health criticized items that weren’t even relevant to the proposal. The turndown by the National Dairy Council was not a surprise. Enig had earlier learned that Phil
Lofgren, then head of research at the Dairy Council, had philosophical ties to the lipid hypothesis. Enig tried to alert Senator Mettzanbaum from Ohio, who was involved in the dietary recommendations debate, but got nowhere.

A USDA official confided to the Maryland research group that they “would never get money as long as they pursued the trans work.” Nevertheless they did pursue it. Sampagna, Keeney and a few graduate students, funded jointly by the USDA and the university, spend thousands of hours in the laboratory analyzing the trans fat content of hundreds of commercially available foods. Enig worked as a graduate student, at times with a small stipend, at times without pay, to help direct the process of tedious analysis. The long arm of the food industry did its best to put a stop to the group’s work by pressuring the USDA to pull its financial support of the graduates students doing the lipid analyses, which the
University of Maryland received due to its status as a land grant college.

In December of 1982, Food Processing carried a brief preview of the University of Maryland research and five months later the same journal printed a blistering letter from Edward Hunter on behalf of the Institute of Shortening and Edible Oils. The University of Maryland studies on trans fat content in common foods had obviously struck a nerve. Hunter stated that the Bailar, Applewhite and Meyer letters that had appeared in Federation Proceedings five years earlier, “severely criticized and discredited” the conclusions reached by
Enig and her colleagues. Hunter was concerned that Enig’s group would exaggerate the amount of trans found in common foods. He cited ISEO data indicating that most margarines and shortenings contain no more than 35% and 25% trans respectively, and that most contain considerably less.

What Enig and her colleagues actually found was that many margarines indeed contained about 31% trans fat – later surveys by others revealed that Parkay
margarine contained up to 45% trans – while many shortenings found ubiquitously in cookies, chips and baked goods contained more than 35%. She also discovered that many baked goods and processed foods contained considerably more fat from partially hydrogenated vegetable oils than was listed on the label. The finding of higher levels of fat in products made with partially hydrogenated oils was confirmed by Canadian government researchers many years later, in 1993.

Final results of Enig’s ground-breaking compilation were published in the October 1983 edition of the Journal of the American Oil Chemists Society. Her analyses of more than 220 food items, coupled with food disappearance data, allowed University of Maryland researchers to confirm earlier estimates that the
average American consumed at least 12 grams of trans fat per day, directly contradicting ISEO assertions that most Americans consumed no more that six to eight grams of trans fat per day. Those who consciously avoided animal fats typically consumed far more than 12 grams of trans fat per day.

The ensuing debate between Enig and her colleagues at the University of Maryland, and Hunter and Applewhite of the ISEO, took the form of a cat and mouse game running through several scientific journals. Food Processing declined to publish Enig’s reply to Hunter’s attack. Science Magazine published another critical letter by Hunter in 1984, in which he misquoted Enig, but refused to print her rebuttal. Hunter continued to object to assertions that average consumption of trans fat in partially hydrogenated margarines and shortenings could exceed six to eight grams per day, a concern that Enig found puzzling when coupled with the official ISEO position that trans fatty acids were innocuous and posed no threat to public health.

The problem with the 40 years of NHLBI-sponsored research on lipids, cholesterol and heart disease was that it had not produced many answers – at least not many answers that the NHLBI was pleased with. The ongoing Framingham Study found that there was virtually no difference in coronary heart disease “events” for individuals with cholesterol levels between 205 mg/dL and 294 mg/Dl – the vast majority of the US population. Even for those with extremely high cholesterol levels – up to almost 1200 mg/dL, the difference in CHD events compared to those in the normal range was trivial.

This did not prevent Dr. William Kannel, then Framingham Study Director, from making claims about the Framingham results. “Total plasma cholesterol” he said, “is a powerful predictor of death related to CHD.” It wasn’t until more than a decade later that the real findings at Framingham were published – without fanfare – in the Archives of Internal Medicine, an obscure journal. “In Framingham, Massachusetts,” admitted Dr. William Castelli, Kannel’s successor “the more saturated fat one ate, the more cholesterol one ate, the more calories one ate, the lower people’s serum cholesterol. . . we found that the people who ate the most cholesterol, ate the most saturated fat, ate the most calories weighed the least and were the most physically active.”

NHLBI’s Multiple Risk Factor Intervention Trial (MRFIT) studied the relationship between heart disease and serum cholesterol levels in 362,000 men and found that annual deaths from CHD varied from slightly less than one per thousand at serum cholesterol levels below 140 mg/dL, to about two per thousand for serum cholesterol levels above 300 mg/dL, once again a trivial difference.

Dr. John LaRosa of the American Heart Association claimed that the curve for CHD deaths began to “inflect” after 200 mg/dL, when in fact the “curve” was a very gradually sloping straight line that could not be used to predict whether serum cholesterol above certain levels posed a significantly greater risk for heart disease. One unexpected MRFIT finding the media did not report was that deaths from all causes – cancer, heart disease, accidents, infectious disease, kidney failure, etc. – were substantially greater for those men with cholesterol levels below 160 mg/dL.31

What was needed to resolve the validity of the lipid hypothesis once and for all was a well-designed, long-term diet study that compared coronary heart disease
events in those on traditional foods with those whose diets contained high levels of vegetable oils – but the proposed Diet-Heart study designed to test just that had been cancelled without fanfare years earlier. In view of the fact that orthodox medical agencies were united in their promotion of margarine and vegetable oils over animal foods containing cholesterol and animal fats, it is surprising that the official literature can cite only a handful of experiments indicating that dietary cholesterol has “a major role in determining blood
cholesterol levels.”

One of these was a study involving 70 male prisoners directed by Fred Mattson – the same Fred Mattson who had pressured the American Heart Association into removing any reference to hydrogenated fats from their diet-heart statement a decade earlier. Funded in part by Procter and Gamble, the research contained a number of serious flaws: selection of subjects for the four groups studied was not randomized; the experiment inexcusably eliminated “an equal number of subjects with the highest and lowest cholesterol values;” twelve additional subjects dropped out, leaving some of the groups too small to provide valid conclusions; and statistical manipulation of the results was shoddy. But the biggest flaw was that the subjects receiving cholesterol did so in the form of reconstituted powder – a totally artificial diet.

Mattson’s discussion did not even address the possibility that the liquid formula diet he used might affect blood cholesterol differently than would a whole foods diet when, in fact, many other studies indicated that this is the case. The culprit, in fact, in liquid protein diets appears to be oxidized cholesterol, formed during the high-temperature drying process, which seems to initiate the buildup of plaque in the arteries. Powdered milk containing oxidized cholesterol is added to reduced fat milk – to give it body – which the American public has accepted as a healthier choice than whole milk. It was purified, oxidized cholesterol that Kritchevsky and others used in their experiments on vegetarian rabbits.

The NHLBI argued that a diet study using whole foods and involving the whole population would be too difficult to design and too expensive to carry out. But the NHLBI did have funds available to sponsor the massive Lipid Research Clinics Coronary Primary Prevention Trial in which all subjects were placed on a diet low in cholesterol and saturated fat. Subjects were divided into two groups, one of which took a cholesterol-lowering drug and the other a placebo.

Working behind the scenes, but playing a key role in both the design and implementation of the trials, was Dr. Fred Mattson, formerly of Procter and Gamble. An interesting feature of the study was the fact that a good part of the trial’s one-hundred-and-fifty-million-dollar budget was devoted to group sessions in which trained dieticians taught both groups of study participants how to choose “heart-friendly” foods – margarine, egg replacements, processed cheese, baked goods made with vegetable shortenings, in short the vast array of manufactured foods awaiting consumer acceptance.

As both groups received dietary indoctrination, study results could support no claims about the relation of diet to heart disease. Nevertheless, when the results were released, both the popular press and medical journals portrayed the Lipid Research Clinics trials as the long-sought proof that animal fats were the cause of heart disease. Rarely mentioned in the press was the ominous fact that the group taking the cholesterol-lowering drugs had an increase in deaths from cancer, stroke, violence and suicide.

LRC researchers claimed that the group taking the cholesterol-lowering drug had a 17% reduction in the rate of CHD, with an average cholesterol reduction of
8.5%. This allowed LRC trials Director Basil Rifkind to claim that “for each 1% reduction in cholesterol, we can expect a 2% reduction in CHD events.” The statement was widely circulated even though it represented a completely invalid representation of the data, especially in light of the fact that when the lipid group at the University of Maryland analyzed the LRC data, they found no difference in CHD events between the group taking the drug and those on the placebo.

A number of clinicians and statisticians participating in a 1984 Lipid Research Clinics Conference workshop, including Michael Oliver and Richard Krommel, were highly critical of the manner in which the LRC results had been tabulated and manipulated. The conference, in fact, went very badly for the NHLBI, with critics of the lipid hypothesis almost outnumbering supporters. One participant, Dr. Beverly Teter of the University of Maryland’s lipid group, was delighted with the state of affairs. “It’s wonderful'” she remarked to Basil Rifkind, study coordinator, “to finally hear both sides of the debate. We need more meetings like this” His reply was terse and sour: “No we don’t.”

Dissenters were again invited to speak briefly at the NHLBI-sponsored National Cholesterol Consensus Conference held later that year, but their views were not included in the panel’s report, for the simple reason that the report was generated by NHLBI staff before the conference convened. Dr. Teter discovered this when she picked up some papers by mistake just before the conference began, and found they contained the consensus report, already written, with just a few numbers left blank. Kritchevsky represented the lipid hypothesis camp with a humorous five-minute presentation, full of ditties. Edward Ahrens, a respected researcher, raised strenuous objections about the “consensus,” only to be told that he had misinterpreted his own data, and that if he wanted a conference to come up with different conclusions, he should pay for it himself.

The 1984 Cholesterol Consensus Conference final report was a whitewash, containing no mention of the large body of evidence that conflicted with the
lipid hypothesis. One of the blanks was filled with the number 200. The document defined all those with cholesterol levels above 200 mg/dL as “at risk” and called for mass cholesterol screening, even though the most ardent supporters of the lipid hypothesis had surmised in print that 240 should be the magic cutoff point. Such screening would, in fact, need to be carried out on a massive scale as the federal medical bureaucracy, by picking the number 200, had defined the vast majority of the American adult population as “at risk.”

The report resurrected the ghost of Norman Jolliffe and his Prudent Diet by suggesting the avoidance of saturated fat and cholesterol for all Americans now defined as “at risk,” and specifically advised the replacement of butter with margarine.

The Consensus Conference also provided a launching pad for the nationwide National Cholesterol Education Program, which had the stated goal of “changing physicians’ attitudes.” NHLBI-funded studies had determined that while the general population had bought into the lipid hypotheses, and was dutifully using margarine and buying low-cholesterol foods, the medical profession remained skeptical. A large “Physicians Kit” was sent to all doctors in America, compiled in part by the American Pharmaceutical Association, whose representatives served on the NCEP coordinating committee. Doctors were taught the importance of cholesterol screening, the advantages of cholesterol-lowering drugs and the unique benefits of the Prudent Diet. NCEP materials told every doctor in America to recommend the use of margarine rather than butter! Amen!

One of the excellent books that I have used extensively to prepare this lecture which I highly recommend every household to own is entitled “Nourishing Traditions: A Cookbook That Challenges Politically Correct Nutrition and the Diet Dictorates by Sally Fallon and Mary Enig. You can order it from, and it is also available in a Kindle version.

The Food and Drug Administration have not evaluated these statements. This information and products are not intended to diagnose, treat, cure or prevent any disease. For all serious health problems, consult a qualified health professional.

Taken From: The Weston A. Price Foundation website at

Read other interesting articles such as:

Shocking Facts About Low-Fat Diets – Part 1

Mitochondria: Key to Health and Longevity

Online Consultations With Dr. George

Important Articles

Related Posts

August 6, 2023

Understanding Fibromyalgia and Natural Approaches to Pain-Free Living Fibromyalgia is a chronic, misunderstood condition characterized by widespread musculoskeletal pain, fatigue, and tenderness. It affects millions of people worldwide, predominantly women. Fibromyalgia is challenging to diagnose and treat due to its complex and multifactorial nature. While conventional medicine can relieve symptoms, a natural approach to managing fibromyalgia may offer a more holistic and individualized solution. This article will explore fibromyalgia, its potential causes, and the natural approaches that promote pain-free living. Understanding Fibromyalgia Fibromyalgia is a chronic pain condition that primarily affects the body's muscles, tendons, and ligaments. Its hallmark symptom is widespread pain, often accompanied by fatigue, sleep disturbances, and cognitive difficulties, commonly called "fibro fog." The exact cause of fibromyalgia remains unknown, but researchers believe it involves a combination of factors, including: Central Sensitization: Fibromyalgia involves central sensitization, a condition where the central nervous system becomes overly sensitive to pain signals, amplifying pain sensations. Neurotransmitter Imbalances: Disruptions in neurotransmitters, such as serotonin and dopamine, may contribute to fibromyalgia symptoms. Genetics: There may be a genetic predisposition to fibromyalgia, with a family history of the condition being a potential risk factor. Physical Trauma and Stress: Physical injuries, infections, or significant emotional stress can trigger or worsen fibromyalgia symptoms. Natural Approaches to Pain-Free Living The natural approach to managing fibromyalgia focuses on improving overall well-being, addressing potential triggers, and reducing pain through non-pharmacological means. Some key natural approaches include: Mind-Body Therapies: Mind-body practices, such as meditation, yoga, and tai chi, can …

Irritable Bowel Syndrome
August 6, 2023

Understanding Irritable Bowel Syndrome (IBS) IBS is a functional gastrointestinal disorder, meaning there are no structural abnormalities or specific diagnostic markers to identify the condition. Instead, the diagnosis is based on symptoms that fit specific criteria outlined in clinical guidelines. The primary symptoms of IBS include: Abdominal pain or discomfort Bloating and distension Altered bowel habits (constipation, diarrhea, or alternating between the two) Relief of symptoms after bowel movement It's essential to rule out other gastrointestinal conditions with similar symptoms before diagnosing IBS. IBS is often classified into three subtypes based on predominant bowel habits: IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), and mixed IBS (IBS-M). Potential Causes of IBS The exact cause of IBS remains unclear, and it likely involves a combination of factors. Some potential causes and triggers of IBS include: Gut-Brain Axis: The gut-brain axis plays a crucial role in IBS, where communication between the gut and the brain is disrupted, leading to abnormal gut motility and sensitivity. Microbiome Imbalance: An imbalance in the gut microbiome, the vast community of microbes in the intestines, has been linked to IBS symptoms. Food Sensitivities: Some individuals with IBS may have sensitivities to certain foods, such as lactose or gluten, which can trigger symptoms. Stress and Anxiety: Psychological factors, including stress and anxiety, can exacerbate IBS symptoms. Intestinal Inflammation: In some cases, low-grade inflammation in the intestines may contribute to IBS symptoms. Naturopathic Approaches for Managing IBS Naturopathic medicine is a holistic system of healthcare that emphasizes the body's …

Female Infertility
August 2, 2023

Female Infertility Patient Testimonial - Case 3, Mrs. P, age 48 Female Infertility Medical diagnosis: Mrs. P had suffered from gynaecological problems for longer than 22 years and headaches for more than 10 years. She had seen a total of 5 gynaecologists who tried contraceptive pills, IV hormonal injections to stimulate ovulation, and benign, fibrotic endometrial atrophic polyp with fibrosis, which was surgically removed in 2000 with the suggestion that she have a total hysterectomy that she refused. Six months later she had a D & C with histopathological analysis that found nothing abnormal. Blood hormonal assays showed high levels of testosterone that was probably responsible for her hirsutism in arms and legs. Polycystic ovaries were diagnosed by ultrasound scan in 1999 but no treatment was given for this. The sonography report read: “Both ovaries have multiple (at least 15 on each side) small follicular cysts with diameters not exceeding 5 mm. Her periods were very irregular with cycles ranging from 40-60 days. She also suffered from frequent migraines and chronic fatigue. Holistic diagnosis: Mrs. P came to me not so much for the sterility problem as she was already 47 years old and as they had been trying for over 25 years to have more children, she had given up on any chance of getting pregnant. She was more concerned about her increasing weight, her hirsutism (hair on the body), and headaches that were getting worse and were more and more frequent. Therefore, only a few tests were run and …

BICOM Bioresonance Device
July 12, 2023

Bicom Bioresonance Device Unveiling the Power of Energetic Healing Introduction The Bicom Bioresonance Device is a revolutionary tool that harnesses the principles of bioresonance therapy to promote healing and restore balance within the body. This advanced technology utilizes electromagnetic frequencies to detect and harmonize energetic imbalances, providing a non-invasive and holistic approach to well-being. Understanding Bioresonance Therapy Bioresonance therapy is based on the principle that every living organism emits electromagnetic frequencies, and these frequencies can provide valuable insights into an individual's health status. Bioresonance devices are designed to measure and analyze these frequencies to identify imbalances and assist in restoring optimal health. How Does the Bicom Bioresonance Device Work? The Bicom Bioresonance Device works by detecting and analyzing the electromagnetic frequencies emitted by the body. Here's how it operates: Analysis and Assessment: The device employs specialized sensors and electrodes to measure the electromagnetic frequencies emitted by the patient. These frequencies are then analyzed to identify imbalances, stressors, and potential underlying causes of health issues. Frequency Harmonization: Once the imbalances are identified, the device utilizes specific electromagnetic frequencies to harmonize and balance the body's energy field. The device emits corrective frequencies to counteract the disruptive frequencies detected during the assessment, helping restore the body's natural equilibrium. Benefits of the Bicom Bioresonance Device Non-Invasive and Painless: The Bicom Bioresonance Device offers a non-invasive and painless approach to health assessment and therapy. It does not require any needles or physical intervention, making it suitable for individuals of all ages, including children and those …

June 28, 2023

Spiritual Psychotherapy What is Pastoral or Spiritually-Focussed Psychotherapy? Pastoral or spiritually-focused psychotherapy recognizes the integral connection between an individual's spirituality and their mental and emotional well-being. This approach combines psychological principles with spiritual beliefs and practices to support individuals in their healing and personal growth journeys. Benefits of Spiritually-Focussed Psychotherapy Here are some benefits of pastoral or spiritually focused psychotherapy and the mind-heart connection: Integration of Spiritual Beliefs: Pastoral psychotherapy acknowledges the significance of an individual's spiritual beliefs and incorporates them into the therapeutic process. By integrating spirituality into therapy, individuals can explore their values, beliefs, and sense of purpose, and find meaning and guidance within their spiritual framework. This can foster a sense of wholeness and provide a solid foundation for personal growth. Enhanced Emotional and Mental Well-being: Spirituality can provide individuals with a source of strength, hope, and resilience during challenging times. By addressing spiritual concerns and incorporating spiritual practices, pastoral psychotherapy can help individuals find comfort, inner peace, and emotional healing. It can offer a framework for coping with stress, grief, and trauma, and promote emotional well-being. Increased Self-Awareness and Self-Reflection: Spiritual exploration often involves introspection, self-reflection, and self-discovery. Pastoral psychotherapy encourages individuals to delve into their inner world, examining their values, beliefs, and life choices. This process can lead to increased self-awareness, helping individuals gain insight into their emotions, thoughts, and behaviors. It can also facilitate personal growth and transformation. Nurturing the Mind-Heart Connection: The mind-heart connection recognizes the interplay between cognitive processes and emotional experiences. …

metabolic typing
June 24, 2023

METABOLIC TYPING DIETUnlocking Optimal Health with Metabolic Typing: Understanding its Advantages and ApplicationsIntroductionMetabolic typing is an individualized approach to nutrition and health that recognizes the unique biochemical needs of each person. By understanding an individual's metabolic type, this approach aims to optimize health by providing tailored dietary recommendations and lifestyle strategies.Understanding Metabolic TypingMetabolic typing is based on the principle that individuals have distinct metabolic profiles, which influence how their bodies process and utilize nutrients. It recognizes that different people have varying nutritional requirements, and a one-size-fits-all approach may not yield optimal results. Metabolic typing helps identify an individual's metabolic type and provides personalized guidelines for diet, exercise, and lifestyle adjustments.Advantages of Metabolic Typing:Personalized Nutrition: One of the key advantages of metabolic typing is the ability to tailor nutrition recommendations to an individual's unique metabolic needs. By understanding how different foods affect an individual's metabolism, metabolic typing helps identify the optimal macronutrient ratios (carbohydrates, proteins, and fats) for each person. This personalized nutrition approach promotes better nutrient absorption, energy production, and overall metabolic balance.Improved Energy and Vitality: By aligning dietary choices with an individual's metabolic type, metabolic typing aims to enhance energy levels and vitality. When individuals consume foods that are appropriate for their metabolism, their bodies can efficiently convert nutrients into usable energy, leading to increased vitality, improved physical performance, and reduced feelings of fatigue.Weight Management and Body Composition: Metabolic typing takes into account the relationship between metabolism and body composition. By understanding an individual's metabolic type, recommendations can be …

Leave a Reply

Your email address will not be published. Required fields are marked *